Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The discovery of genes encoding the volume-regulated anion channel (VRAC) has enabled detailed exploration of its cell type-specific roles in the brain. LRRC8A (SWELL1) is the essential VRAC subunit. We observed seizure-induced, subunit-specific changes in microglial VRAC expression and investigated its function using conditional knockout (cKO) of LRRC8A in microglia. SWELL1 cKO mice exhibited a male-specific increase in kainate-induced seizure severity yet showed paradoxical neuroprotection against seizure-associated neuronal loss. Mechanistically, SWELL1 deletion led to a cell-autonomous reduction in microglial density and decreased release of VRAC-permeable neuroactive metabolites, including taurine, GABA, and glutamate in culture. Additionally, impaired phagocytic kinetics and reduced lysosomal biogenesis contributed to the observed neuroprotection. These findings reveal novel roles for microglial VRAC in regulating seizure outcomes and microglia-neuron interactions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12154700 | PMC |
| http://dx.doi.org/10.1101/2025.05.26.656163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Enhancing microglial antioxidant capacity via the ascorbate transporter SVCT2 delays onset and modifies disease progression in mouse models of Alzheimer's disease.
Redox Biol
August 2025
i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Porto, Portugal; IBMC - Instituto de Biologia Molecular e Celular, Porto, Portugal; Departamento de Biomedicina - Unidade de Biologia Experimental, Faculdade de Medicina da Universidade do Porto, Porto, Portugal. Elec
Despite clear evidence that vitamin C levels are depleted in the brains of Alzheimer's disease (AD) patients, dietary supplementation has consistently failed in clinical trials, suggesting a critical bottleneck not in systemic supply, but in its transport into brain cells. Here, we identify this bottleneck as a progressive downregulation of the ascorbate transporter, Slc23a2, also known as SVCT2, in microglia. Then we hypothesized that bypassing this cellular deficiency via targeted SVCT2 overexpression in microglia could either prevent the onset of pathology or rescue established functional deficits.
View Article and Find Full Text PDFTargeting Drp1 in Cerebral Ischemia-Reperfusion Injury: Mechanisms and Therapeutic Implications.
CNS Neurosci Ther
August 2025
Department of Neurology, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
Background: Cerebral ischemia-reperfusion injury (CIRI) arises after blood flow restoration in stroke, where reperfusion paradoxically triggers mitochondrial dysfunction, apoptosis, inflammation, and oxidative stress. Dynamin-related protein 1 (Drp1), a regulator of mitochondrial fission, amplifies these cascades by promoting apoptosis, inflammatory signaling, and calcium imbalance.
Methods: This review synthesizes recent studies on Drp1 in CIRI, focusing on its regulatory roles in mitochondrial dynamics and neuronal injury, and evaluating therapeutic strategies through pharmacological and genetic modulation.
Somatostatin and its receptors involvement in sevoflurane-induced neurotoxicity: a narrative review.
BMC Anesthesiol
August 2025
Department of Anesthesiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
As a widely used pediatric anesthetic, sevoflurane presents a paradoxical neurodevelopmental risk during vulnerable brain maturation periods. This review synthesizes emerging evidence on sevoflurane-induced developmental neurotoxicity, with a focus on somatostatin (SST)-SSTR4 signaling and its downstream effects on synaptic integrity. Key findings reveal that sevoflurane exposure disrupts excitatory-inhibitory balance by upregulating hippocampal SST expression, suppressing glutamatergic synaptic markers (vesicular glutamate transporter 1 (vGLUT1), PSD95), and impairing cAMP/PKA signaling-a pathway essential for AMPA receptor trafficking and synaptic plasticity.
View Article and Find Full Text PDFCoumarin-Chalcone derivatives as promising antioxidant agents targeting ischemia/reperfusion injury through Nrf2 pathway activation.
Bioorg Chem
July 2025
Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran; Department of Medicinal Chemistry, School of
Ischemic stroke remains a major global cause of mortality. Reperfusion therapy with thrombolysis paradoxically raises reactive oxygen species (ROS) and causes cerebral ischemia-reperfusion injury (CIRI). To address this challenge, antioxidants, which directly neutralize ROS or indirectly activate the KEAP1/Nrf2/ARE pathway, have emerged as promising strategies.
View Article and Find Full Text PDFMultidimensional Toxicity of Organophosphate Pesticides and Mitigation Strategies for Agricultural Sustainability.
J Agric Food Chem
July 2025
College of Arts and Sciences, Northeast Agricultural University, Harbin 150030, P. R. China.
Organophosphate pesticides (OPs) remain essential yet controversial in global agriculture, demanding an urgent resolution of their efficacy-environmental protection paradox. This review provides an in-depth analysis of the toxicity mechanisms of OPs, primarily through oxidative stress induction, acetylcholinesterase (AChE) inhibition-mediated neurotoxicity, endocrine disruption, and multiorgan pathological effects. We highlight promising mitigation strategies, including natural antioxidants, advanced neuroprotective agents, neuroinflammatory inhibitors, nutraceutical interventions, and others, which synergistically alleviate the toxicity of OPs.
View Article and Find Full Text PDF